Holding company building a portfolio of regenerative-health assets, including a patented endothelial glycocalyx imaging system and a proprietary formula to regenerate and protect the microvascular system. Targets healthcare institutions, practitioners and wellness consumers via direct-to-institution/practitioner/consumer channels, offering exclusive, clinically backed diagnostics and therapeutic products.